e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
Rare diffuse lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Abnormalities between down regulation of cyclooxygenase-2 and up-regulation of grow factors in patients with systemic sclerosis
E. R. Parra, F. Lin, V. Capelozzi (São Paulo, Brazil)
Source:
Annual Congress 2011 - Rare diffuse lung diseases
Session:
Rare diffuse lung diseases
Session type:
Thematic Poster Session
Number:
640
Disease area:
Interstitial lung diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. R. Parra, F. Lin, V. Capelozzi (São Paulo, Brazil). Abnormalities between down regulation of cyclooxygenase-2 and up-regulation of grow factors in patients with systemic sclerosis. Eur Respir J 2011; 38: Suppl. 55, 640
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Definition and history of sarcoidosis
Evidence of early abnormal airways’ inflammation in children with type 1 diabetes
Related content which might interest you:
Genetic polymorphisms of inflammatory cytokines and endothelial dysfunction factors: role in patients with sarcoidosis
Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues
Year: 2019
Increased endothelial and epithelial apoptosis play a central role in the pathogenesis of systemic sclerosis and idiopathic pulmonary fibrosis
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008
Survival and prognostic factors in progressive systemic sclerosis with lung involvement
Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease
Year: 2009
Metabolic profiling of pulmonary vascular phenotypes in systemic sclerosis
Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Year: 2020
IGFBP-2: a new pathway in systemic sclerosis associated interstitial lung disease
Source: International Congress 2019 – Connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis: what’s new?
Year: 2019
Etiologic factors in patients with systemic sclerosis
Source: Eur Respir J 2006; 28: Suppl. 50, 98s
Year: 2006
CCL18 as marker of disease progression in systemic sclerosis
Source: Annual Congress 2012 - Cystic lung diseases: lung granulomatosis
Year: 2012
Increased mRNA expression of collagen V gene in pulmonary fibrosis of systemic sclerosis
Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease
Year: 2009
Multiplex immune serum biomarker profiling in sarcoidosis and systemic sclerosis
Source: Eur Respir J 2009; 34: 1376-1382
Year: 2009
Involvement of epigenetic factor in regulation of steroid resistant bronchial asthma patients
Source: International Congress 2018 – Identification of therapeutic targets for asthma
Year: 2018
Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis
Source: Eur Respir J, 51 (4) 1701197; 10.1183/13993003.01197-2017
Year: 2018
Vascular endothelial growth factors and matrix metalloproteinases serum levels for LAM diagnosis in patients with sporadic LAM and tuberous sclerosis
Source: International Congress 2018 – Progress in rare interstitial lung diseases
Year: 2018
Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis
Source: Eur Respir J 2011; 38: 1355-1360
Year: 2011
Serum‘s factors inhibit erythropoiesis in patients with idiopathic pulmonary fibrosis(IPF)
Source: Eur Respir J 2003; 22: Suppl. 45, 227s
Year: 2003
Role of cytokines in regulation of inflammatory and protective reactions in progression of pulmonary MDR tuberculosis
Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care
Year: 2007
The effect of augmentation therapy on systemic and pulmonary inflammation markers in α1-antitrypsin deficiency patients
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010
Dysregulation of the “inflammatory reflex” with abnormal neurohumoral activation may contribute to proinflammatory activity driving the progression of COPD
Source: Eur Respir J, 51 (6) 1800806; 10.1183/13993003.00806-2018
Year: 2018
Effect of cyclooxygenase-2 inhibition on lung inflammation and hypoxia-inducible factor-1 signalling in COPD model
Source: International Congress 2017 – Insight into the pathogenesis of emphysema and pneumonia
Year: 2017
The role of TLR4 gene expression in pathogenesis of multiple organ dysfunction syndrome in the elderly rats
Source: Eur Respir J 2005; 26: Suppl. 49, 559s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept